Persodia Research

Tag: insight

  • IVD Industry Monograph No. 3

    IVD Industry Monograph No. 3

    —

    by

    Miguel Oliveira

    Beyond Market Access – Foundations for Sustaining Europe’s IVD Leadership Europe’s diagnostics industry shows visible continuity but declining structural durability. IVD’s share of healthcare expenditure fell from 0.80% in 2009 to 0.60% in 2023. Real growth is weak. Capital duration is stressed. Regulatory and evidence obligations fall disproportionately on smaller suppliers. Five structural gaps—competitiveness, fixed-burden…

  • IVD Industry Monograph No. 2

    IVD Industry Monograph No. 2

    —

    by

    Miguel Oliveira

    Earning Position: How Evidence Becomes Authority Diagnostics fail not analytically but through Evidence Escape: evidence does not automatically become clinical authority. Seven evidence domains govern adoption—analytical, clinical, regulatory, economic, operational. Strength in one domain cannot compensate for weakness elsewhere. The binding-constraint principle identifies the missing domain preventing adoption. Connected laboratories are evidence-generating assets, not merely…

  • IVD Industry Monograph No. 1

    IVD Industry Monograph No. 1

    —

    by

    Miguel Oliveira

    Crossing from Analytical to Diagnostics: The Difficulty is the Moat Most analytical technologies never reach clinical diagnostics—not due to inadequate performance, but because clinical markets demand structural transformation: from flexibility to constraint, standardization and manufacturer accountability. The crossing requires seven simultaneous conditions across three phases. This structural distance is not a barrier to avoid but…

  • The Book – INSIGHT 6

    The Book – INSIGHT 6

    —

    by

    Miguel Oliveira

    Health Intelligence Will Not Remove Constraint. It Will Densify It. The next frontier is not more data. It is the ability to sustain trustworthy meaning across systems. Why does this matter now? Artificial intelligence is accelerating expectations across healthcare. Diagnostics sits close to the centre of that discussion because it already generates structured biological information…

  • The Book – INSIGHT 5

    The Book – INSIGHT 5

    —

    by

    Miguel Oliveira

    Strategy in Diagnostics Is Selection Under Constraint. The central question is not which opportunity appears most attractive. It is which exposure the organisation is prepared to inhabit. Why does this matter now? Diagnostics strategy is often presented as a search for opportunity. Which technology should be developed? Which market should be entered? Which partnership should…

  • The Book – INSIGHT 4

    The Book – INSIGHT 4

    —

    by

    Miguel Oliveira

    Diagnostic Value Completes Outside the Firm. The manufacturer creates the product. The system determines whether its value becomes real. Why does this matter now? Diagnostic companies invest in research, development, validation, manufacturing, regulatory compliance and deployment. Yet the value of a diagnostic product is rarely completed inside the firm that created it. It is completed…

  • The Book – INSIGHT 3

    The Book – INSIGHT 3

    —

    by

    Miguel Oliveira

    The Same Diagnostic System Can Be Infrastructure in One Market and Strain in Another. Technology may stabilize globally. Deployment never does. Why does this matter now? Diagnostics companies often speak of global scale as though it were a movement towards uniformity. The technology travels. The product receives regulatory approval. The analytical performance remains consistent. Yet…

  • The Book – INSIGHT 2

    The Book – INSIGHT 2

    —

    by

    Miguel Oliveira

    Integration Secured Scale. It Also Reduced Reversibility. Once laboratories became systems of systems, operational coherence became both a strategic asset and a structural exposure. Why does this matter now? Laboratory integration is usually presented as a straightforward improvement: greater automation, shorter turnaround times, better connectivity and more efficient workflows. All of those benefits are real.…

  • The Book – INSIGHT 1

    The Book – INSIGHT 1

    —

    by

    Miguel Oliveira

    The IVD Industry Did Not Invent Biology. It Stabilized It. The first industrial achievement of diagnostics was not measurement. It was making trust reproducible. Why does this matter now? Diagnostics innovation is frequently discussed as a sequence of scientific breakthroughs: new biomarkers, greater sensitivity, broader menus and increasingly sophisticated technologies. That description is incomplete. The…

  • Persodia Research Founding Book

    Persodia Research Founding Book

    —

    by

    Miguel Oliveira

    Inside the Clinical Diagnostics Industry: Constraints Shaping Strategy — Towards Health Intelligence The foundational Persodia book examines diagnostics as a system governed by enduring structural constraints and provides the analytical framework from which Persodia Research was established. Book NotePublished February 2026Miguel Oliveira Why does this matter now? Diagnostics strategy is often discussed through products, technologies…